MEGUMI LTD exits Cardiff-based biotech Llusern Scientific
Published
MEGUMI LTD has exited the cap table of Llusern Scientific Ltd, according to the company's latest confirmation statement. The investor disposed of its entire holding of 646 Ordinary shares during the period ending 30 June 2026.
Based in Cardiff and founded in 2020, Llusern Scientific develops and manufactures a portable, LAMP-based molecular diagnostic platform. Its technology focuses on a test panel for the rapid detection of urinary tract infections, providing point-of-care solutions for near-patient healthcare settings.
University of South Wales Commercial Services remains the largest shareholder listed in the filing with 39,000 shares. Other existing investors that continue to hold stakes in the business include Ralf Guetlein Beteiligungs GmbH with 21,929 shares and EKF Diagnostics Holdings PLC with 2,100 shares. Blackwood Embedded Solutions Ltd also remains on the cap table with a holding of 862 shares. These updates confirm the ownership structure of the Welsh biotechnology firm as of its most recent filing on 13 July 2026.
Shareholder data
Source: Companies House confirmation statement (CS01) — period to , filed .
Changes in this confirmation statement
| Type | Shareholder | Shares | Change | Share classes |
|---|---|---|---|---|
| Exited | MEGUMI LTD | 646 | — | ORDINARY 646 |
Current shareholders (5)
| Shareholder | Total shares | Share classes |
|---|---|---|
| UNIVERSITY OF SOUTH WALES COMMERCIAL SERVICES | 39,000 | B ORDINARY 8,174 ORDINARY 30,826 |
| RALF GUETLEIN BETEILIGUNGS GMBH | 21,929 | ORDINARY 21,929 |
| CROWDCUBE NOMINEES LTD | 2,953 | ORDINARY 2,953 |
| EKF DIAGNOSTICS HOLDINGS PLC | 2,100 | ORDINARY 2,100 |
| BLACKWOOD EMBEDDED SOLUTIONS LTD | 862 | ORDINARY 862 |
Contact the editorial team at [email protected]